Having secured one of last year’s largest funding rounds, AI-focused Formation Bio is now eyeing up 545 million euros ($626 ...

Formation Bio’s subsidiary, Libertas Bio, has licensed gusacitinib, an oral dual JAK/SYK inhibitor, to Sanofi.

Buying $1000 In SYK: If an investor had bought $1000 of SYK stock 10 years ago, it would be worth $3,978.93 today based on a ...

In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against other best medical device stocks to buy now. On April 16, CNBC reported that Trump’s tariffs ...

Investors in Stryker Corp (Symbol: SYK) saw new options become available today, for the August 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SYK ...

(Photo credit should read XU CONGJUN / Feature China/Future Publishing via Getty Images) We believe Intuitive Surgical stock (NASDAQ NDAQ: ISRG) is a better pick than Stryker stock (NYSE ...

In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against other stocks that Jim Cramer discusses. When a caller asked about Stryker Corporation (NYSE ...

For the quarter ended December 2023, Stryker (SYK) reported revenue of $5.82 billion, up 11.8% over the same period last year. EPS came in at $3.46, compared to $3.00 in the year-ago quarter.